Name | Number of supported studies | Average coverage | |
---|---|---|---|
cardiac muscle cell | 6 studies | 45% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
heart | 4 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
muscle | 100% | 1432238.55 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.23 | 1 / 1 |
heart | 100% | 181530.36 | 859 / 861 | 0% | 0 | 0 / 0 |
prostate | 9% | 1885.19 | 23 / 245 | 73% | 44.75 | 364 / 502 |
tonsil | 0% | 0 | 0 / 0 | 47% | 56.08 | 21 / 45 |
stomach | 20% | 613.27 | 73 / 359 | 26% | 0.71 | 73 / 286 |
bladder | 0% | 0 | 0 / 21 | 35% | 1.38 | 176 / 504 |
uterus | 0% | 0 | 0 / 170 | 33% | 64.62 | 150 / 459 |
lung | 2% | 345.34 | 11 / 578 | 29% | 3.79 | 340 / 1155 |
lymph node | 0% | 0 | 0 / 0 | 31% | 0.41 | 9 / 29 |
intestine | 2% | 70.23 | 16 / 966 | 24% | 0.83 | 124 / 527 |
ovary | 1% | 29.29 | 2 / 180 | 24% | 0.65 | 102 / 430 |
esophagus | 2% | 317.91 | 32 / 1445 | 19% | 0.80 | 35 / 183 |
pancreas | 1% | 24.91 | 3 / 328 | 20% | 0.72 | 35 / 178 |
skin | 2% | 621.30 | 28 / 1809 | 18% | 0.93 | 86 / 472 |
breast | 2% | 638.88 | 11 / 459 | 11% | 2.70 | 127 / 1118 |
brain | 1% | 45.79 | 27 / 2642 | 11% | 0.18 | 77 / 705 |
thymus | 3% | 419.40 | 19 / 653 | 9% | 3.79 | 53 / 605 |
peripheral blood | 7% | 2026.29 | 63 / 929 | 0% | 0 | 0 / 0 |
liver | 1% | 34.22 | 2 / 226 | 4% | 0.19 | 16 / 406 |
blood vessel | 4% | 1010.42 | 52 / 1335 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 4% | 0.18 | 35 / 901 |
adrenal gland | 1% | 33.45 | 2 / 258 | 2% | 0.11 | 5 / 230 |
adipose | 3% | 229.25 | 33 / 1204 | 0% | 0 | 0 / 0 |
spleen | 1% | 35.62 | 2 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046314 | Biological process | phosphocreatine biosynthetic process |
GO_0005615 | Cellular component | extracellular space |
GO_0005829 | Cellular component | cytosol |
GO_0004111 | Molecular function | creatine kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | CKM |
Protein name | Creatine kinase M-type (EC 2.7.3.2) (Creatine kinase M chain) (Creatine phosphokinase M-type) (CPK-M) (M-CK) |
Synonyms | CKMM |
Description | FUNCTION: Reversibly catalyzes the transfer of phosphate between ATP and various phosphogens (e.g. creatine phosphate). Creatine kinase isoenzymes play a central role in energy transduction in tissues with large, fluctuating energy demands, such as skeletal muscle, heart, brain and spermatozoa. . |
Accessions | ENST00000221476.4 P06732 |